CDT
Conduit Pharmaceuticals Inc.
NASDAQ: CDT · HEALTHCARE · BIOTECHNOLOGY
$2.25
-8.55% today
Updated 2026-04-29
Market cap
$13.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1,177.89
Dividend yield
—
52W range
$2 – $1,754
Volume
0.4M
Conduit Pharmaceuticals Inc. (CDT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-345.00%
Debt/equity
1.09x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-3.66M | — | — | — |
| 2022 | $0.00 | $-4.89M | — | — | — |
| 2023 | $0.00 | $-535000.00 | — | — | — |
| 2024 | $922.22M | $-17.80M | -0.05% | -1.67% | -1.93% |
| 2025 | $2.72B | $237.52M | 37.98% | 11.63% | 8.75% |